نتایج جستجو برای: aml

تعداد نتایج: 12334  

Journal: :Cancers 2023

Acute myeloid leukemia (AML) is a clonal hematopoietic disease that arises from chromosomal and genetic aberrations in precursor cells. AML one of the most common types acute adults; however, it relatively rare overall, comprising about 1% all cancers. In last decade or so, numerous genome-wide association studies (GWAS) have been conducted to screen between hundreds thousands millions variants...

Journal: :Supportive Care in Cancer 2021

Venetoclax along with hypomethylating agents (HMAs) is the new standard therapy for older patients acute myeloid leukemia (AML) not fit intensive frontline induction chemotherapy. associated fatal episodes of tumor lysis syndrome (TLS) in chronic lymphocytic (CLL), and recommendations are its initiation CLL AML inpatient setting close monitoring. Herein, we evaluated safety outpatient venetocla...

Journal: :Haematologica 2007
Ulrike Bacher Torsten Haferlach Wolfgang Kern Claudia Haferlach Susanne Schnittger

BACKGROUND AND OBJECTIVES The precise relationship between myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) is unclear and the role of molecular mutations in leukemic transformation in MDS is controversial. The aim of this study was to clarify the relationship between AML and MDS by comparing the frequency of molecular mutations in the two conditions. DESIGN AND METHODS We comp...

Journal: :genetics in the 3rd millennium 0
mohammad hossein mohammadi naser amirizadeh mehdi allahbakhshian farsani hamideh aghaee nezhad ahmad ahmadzadeh safa najafi

acute myeloblastic leukemia is the most frequent cancer in adults and the patients have a wide range of sub-classes. hla dr negative cases represent one of the major immune-phenotypic classes.  hla-dr is routinely used to distinguish acute promyelocytic leukemia (apl) from other aml subclasses based on the immunophenotype. the tgf-b signaling pathway, as a critical regulator, guides different v...

Journal: :Blood 1993
K Kita H Miwa K Nakase K Kawakami T Kobayashi S Shirakawa I Tanaka C Ohta H Tsutani S Oguma

Forty patients (9 females and 31 males; mean age 41.9 years) with CD7+ acute myelocytic leukemia (AML) were investigated; they were classified into the following subgroups according to French-American-British classification: 15 M1, 18 M2, 3 M4, and 4 M5. Leukemic cells from all the patients were negative for T-cell-specific antigens, surface CD3, and T-cell-receptor molecules. The sex and age d...

Journal: :Blood 2010
Brunangelo Falini Katja Macijewski Tamara Weiss Ulrike Bacher Susanne Schnittger Wolfgang Kern Alexander Kohlmann Hans-Ulrich Klein Marco Vignetti Alfonso Piciocchi Paola Fazi Maria Paola Martelli Antonella Vitale Stefano Pileri Miriam Miesner Antonella Santucci Claudia Haferlach Franco Mandelli Torsten Haferlach

NPM1-mutated acute myeloid leukemia (AML) is a provisional entity in the 2008 World Health Organization (WHO) classification of myeloid neoplasms. The significance of multilineage dysplasia (MLD) in NPM1-mutated AML is unclear. Thus, in the 2008 WHO classification, NPM1-mutated AML with MLD is classified as AML with myelodysplasia (MD)-related changes (MRCs). We evaluated morphologically 318 NP...

Journal: :Cancer genetics and cytogenetics 2010
Birgitte S Preiss Olav J Bergmann Lone S Friis Anne G Sørensen Michael Frederiksen Ole V Gadeberg Torben Mourits-Andersen Birthe Oestergaard Gitte B Kerndrup

During a 15-year period, 161 adult patients were diagnosed with secondary acute myeloid leukemia (s-AML) in the region of Southern Denmark. In 73 patients, the AML diagnosis was preceded by myelodysplastic syndrome (MDS-AML), in 31 patients by an antecedent hematologic disease, and in 57 patients by treatment with chemotherapy and/or irradiation (t-AML). Cytogenetic analysis was carried out in ...

Journal: :international journal of hematology-oncology and stem cell research 0
taher entezari-maleki department of clinical pharmacy, faculty of pharmacy, tabriz university of medical sciences, tabriz,iran safa margedari department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran,iran kheirollah gholami faculty of pharmacy, and research center for rational use of drug, tehran university of medical sciences, tehran,iran molouk hadjibabaie faculty of pharmacy, and research center for rational use of drug, tehran university of medical sciences, tehran,iran mohammad bagher oghazian department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, jamshid salamzadeh department of clinical pharmacy, faculty of pharmacy, shahid beheshti university of medical sciences, tehran,iran

background and aims : adverse drug reactions (adrs) are one of the major leading causes of death in the world. this study was designed and conducted because of the importance of adverse events in the cancer treatment setting and regarding this issue there is no study exploring adverse reactions of acute hematologic malignancy chemotherapy in iranian population. methods : this was a prospective,...

Journal: :international journal of hematology-oncology and stem cell research 0
kourosh sayehmiri department of social medicine and epidemiology, school of medicine, ilam university of medical sciences, iran kamran alimoghaddam hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, iran ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, iran

introduction: the majority of leukemia patients are acute leukemia patients, so that about 70.8% lymphoblastic leukemia were acute lymphoblastic leukemia (all) patients and 66.4 % of myeloid leukemia patients were acute myeloid leukemia (aml) in tehran metropolitan. during the last two decades, intensification of therapy by the use of high-dose cytarabine allogeneic stem cell transplantation in...

2017
Chengyin Min Nathan Moore Jeffrey R. Shearstone Steven N. Quayle Pengyu Huang John H. van Duzer Matthew B. Jarpe Simon S. Jones Min Yang

Acute myeloid leukemia (AML) is a heterogeneous group of hematopoietic stem cell disorders characterized by defects in myeloid differentiation and increased proliferation of neoplastic hematopoietic precursor cells. Outcomes for patients with AML remain poor, highlighting the need for novel treatment options. Aberrant epigenetic regulation plays an important role in the pathogenesis of AML, and...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید